|
|
protein processing
|
GO:0016485 |
226 |
0.544
|
Human |
|
|
single organism membrane organization
|
GO:0044802 |
268 |
0.370
|
Human |
|
|
secretion
|
GO:0046903 |
254 |
0.356
|
|
|
|
regulation of secretion
|
GO:0051046 |
194 |
0.320
|
|
|
|
protein maturation
|
GO:0051604 |
233 |
0.287
|
Human |
|
|
lipid biosynthetic process
|
GO:0008610 |
177 |
0.287
|
|
|
|
regulation of interleukin 8 secretion
|
GO:2000482 |
13 |
0.274
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
162 |
0.271
|
Human |
|
|
protein heterotetramerization
|
GO:0051290 |
3 |
0.265
|
Human |
|
|
negative regulation of serine type peptidase activity
|
GO:1902572 |
2 |
0.233
|
Human |
|
|
positive regulation of transport
|
GO:0051050 |
336 |
0.218
|
Human |
|
|
interleukin 8 secretion
|
GO:0072606 |
14 |
0.213
|
|
|
|
lipid metabolic process
|
GO:0006629 |
381 |
0.205
|
|
|
|
single organism membrane fusion
|
GO:0044801 |
37 |
0.200
|
Human |
|
|
response to other organism
|
GO:0051707 |
261 |
0.199
|
|
|
|
response to bacterium
|
GO:0009617 |
144 |
0.178
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
180 |
0.178
|
Human |
|
|
membrane fusion
|
GO:0061025 |
43 |
0.177
|
Human |
|
|
positive regulation of apoptotic process
|
GO:0043065 |
246 |
0.175
|
|
|
|
endomembrane system organization
|
GO:0010256 |
196 |
0.170
|
Human |
|
|
membrane organization
|
GO:0061024 |
292 |
0.169
|
Human Worm |
|
|
negative regulation of protein processing
|
GO:0010955 |
142 |
0.165
|
Human |
|
|
cellular response to glucocorticoid stimulus
|
GO:0071385 |
4 |
0.158
|
Human |
|
|
secretion by cell
|
GO:0032940 |
226 |
0.158
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
331 |
0.156
|
|
|
|
regulation of cytokine secretion
|
GO:0050707 |
57 |
0.151
|
|
|
|
response to biotic stimulus
|
GO:0009607 |
276 |
0.149
|
|
|
|
lipid localization
|
GO:0010876 |
106 |
0.138
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
303 |
0.131
|
|
|
|
neutrophil clearance
|
GO:0097350 |
1 |
0.126
|
Human |
|
|
lipid transport
|
GO:0006869 |
90 |
0.125
|
|
|
|
protein secretion
|
GO:0009306 |
98 |
0.122
|
|
|
|
positive regulation of cellular component organization
|
GO:0051130 |
376 |
0.116
|
Human |
|
|
cellular response to lipid
|
GO:0071396 |
127 |
0.116
|
Human |
|
|
cytokine production
|
GO:0001816 |
247 |
0.114
|
|
|
|
response to external biotic stimulus
|
GO:0043207 |
261 |
0.113
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
142 |
0.112
|
Human |
|
|
immune response
|
GO:0006955 |
307 |
0.108
|
|
|
|
immune effector process
|
GO:0002252 |
159 |
0.106
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
200 |
0.101
|
|
|
|
regulation of locomotion
|
GO:0040012 |
329 |
0.100
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
249 |
0.099
|
|
|
|
vesicle mediated transport
|
GO:0016192 |
371 |
0.097
|
Human Worm |
|
|
response to organic cyclic compound
|
GO:0014070 |
204 |
0.097
|
Human |
|
|
vesicle organization
|
GO:0016050 |
62 |
0.096
|
Human |
|
|
positive regulation of cell death
|
GO:0010942 |
263 |
0.095
|
|
|
|
membrane lipid metabolic process
|
GO:0006643 |
53 |
0.095
|
|
|
|
positive regulation of vesicle fusion
|
GO:0031340 |
4 |
0.094
|
Human |
|
|
angiogenesis
|
GO:0001525 |
147 |
0.090
|
Human |
|
|
anatomical structure formation involved in morphogenesis
|
GO:0048646 |
284 |
0.090
|
Human |
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
391 |
0.089
|
Human |
|
|
positive regulation of organelle organization
|
GO:0010638 |
195 |
0.089
|
Human |
|
|
cell activation
|
GO:0001775 |
213 |
0.089
|
|
|
|
positive regulation of cysteine type endopeptidase activity
|
GO:2001056 |
79 |
0.088
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
262 |
0.087
|
|
|
|
defense response
|
GO:0006952 |
315 |
0.085
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
293 |
0.085
|
Human |
|
|
regulation of protein transport
|
GO:0051223 |
213 |
0.081
|
|
|
|
sphingolipid metabolic process
|
GO:0006665 |
38 |
0.081
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
232 |
0.080
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
172 |
0.079
|
|
|
|
organic hydroxy compound transport
|
GO:0015850 |
63 |
0.079
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
73 |
0.078
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
268 |
0.078
|
|
|
|
ceramide metabolic process
|
GO:0006672 |
25 |
0.077
|
|
|
|
circulatory system development
|
GO:0072359 |
262 |
0.077
|
Human |
|
|
regulation of immune response
|
GO:0050776 |
201 |
0.076
|
|
|
|
cholesterol transport
|
GO:0030301 |
39 |
0.074
|
|
|
|
multicellular organismal aging
|
GO:0010259 |
3 |
0.073
|
|
|
|
positive regulation of endopeptidase activity
|
GO:0010950 |
84 |
0.073
|
|
|
|
response to hormone
|
GO:0009725 |
175 |
0.072
|
Human |
|
|
alcohol metabolic process
|
GO:0006066 |
114 |
0.071
|
|
|
|
negative regulation of interleukin 8 secretion
|
GO:2000483 |
2 |
0.071
|
|
|
|
regulation of cell migration
|
GO:0030334 |
289 |
0.070
|
|
|
|
response to lipid
|
GO:0033993 |
206 |
0.069
|
Human |
|
|
regulation of phospholipase a2 activity
|
GO:0032429 |
4 |
0.069
|
Human |
|
|
positive regulation of secretion by cell
|
GO:1903532 |
108 |
0.068
|
|
|
|
immune system development
|
GO:0002520 |
195 |
0.066
|
Human |
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
147 |
0.066
|
|
|
|
positive regulation of immune system process
|
GO:0002684 |
283 |
0.065
|
|
|
|
steroid metabolic process
|
GO:0008202 |
94 |
0.064
|
|
|
|
determination of adult lifespan
|
GO:0008340 |
2 |
0.064
|
|
|
|
innate immune response
|
GO:0045087 |
178 |
0.063
|
|
|
|
defense response to other organism
|
GO:0098542 |
129 |
0.063
|
|
|
|
epithelium development
|
GO:0060429 |
227 |
0.062
|
|
|
|
response to inorganic substance
|
GO:0010035 |
127 |
0.062
|
Human |
|
|
epithelium migration
|
GO:0090132 |
119 |
0.062
|
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
132 |
0.062
|
Human |
|
|
regulation of protein maturation
|
GO:1903317 |
150 |
0.061
|
Human |
|
|
defense response to bacterium
|
GO:0042742 |
63 |
0.061
|
|
|
|
exocytosis
|
GO:0006887 |
71 |
0.060
|
|
|
|
response to metal ion
|
GO:0010038 |
84 |
0.059
|
Human |
|
|
organophosphate biosynthetic process
|
GO:0090407 |
163 |
0.059
|
|
|
|
transmembrane transport
|
GO:0055085 |
399 |
0.059
|
Human |
|
|
regulation of cellular component movement
|
GO:0051270 |
334 |
0.058
|
|
|
|
regulation of cell motility
|
GO:2000145 |
299 |
0.057
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
130 |
0.057
|
Human |
|
|
protein oligomerization
|
GO:0051259 |
173 |
0.056
|
Human |
|
|
epithelial cell differentiation
|
GO:0030855 |
141 |
0.056
|
|
|
|
cellular hormone metabolic process
|
GO:0034754 |
41 |
0.056
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
116 |
0.056
|
|
|
|
regulation of cell cycle phase transition
|
GO:1901987 |
126 |
0.054
|
|
|
|
positive regulation of catabolic process
|
GO:0009896 |
310 |
0.053
|
|
|
|
response to cocaine
|
GO:0042220 |
1 |
0.053
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
26 |
0.053
|
|
|
|
protein dephosphorylation
|
GO:0006470 |
81 |
0.052
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
78 |
0.052
|
|
|
|
organic anion transport
|
GO:0015711 |
103 |
0.052
|
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
142 |
0.051
|
|
|
|
organelle fusion
|
GO:0048284 |
36 |
0.051
|
Human |
|
|
anion transport
|
GO:0006820 |
161 |
0.050
|
|
|
|
mapk cascade
|
GO:0000165 |
288 |
0.049
|
|
|
|
actin filament based process
|
GO:0030029 |
224 |
0.049
|
|
|
|
positive regulation of peptidase activity
|
GO:0010952 |
88 |
0.049
|
|
|
|
termination of signal transduction
|
GO:0023021 |
3 |
0.049
|
|
|
|
biological adhesion
|
GO:0022610 |
331 |
0.049
|
|
|
|
positive regulation of immune response
|
GO:0050778 |
159 |
0.047
|
|
|
|
vasculature development
|
GO:0001944 |
181 |
0.047
|
Human |
|
|
response to oxygen containing compound
|
GO:1901700 |
369 |
0.046
|
|
|
|
keratinocyte differentiation
|
GO:0030216 |
36 |
0.046
|
Human |
|
|
interleukin 8 production
|
GO:0032637 |
51 |
0.045
|
|
|
|
neutrophil mediated immunity
|
GO:0002446 |
4 |
0.045
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
230 |
0.045
|
|
|
|
cytokinesis completion of separation
|
GO:0007109 |
3 |
0.045
|
Human |
|
|
regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043281 |
116 |
0.045
|
|
|
|
negative regulation of cytokine production
|
GO:0001818 |
82 |
0.044
|
|
|
|
regulation of protein secretion
|
GO:0050708 |
86 |
0.044
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
177 |
0.044
|
|
|
|
organic acid biosynthetic process
|
GO:0016053 |
97 |
0.044
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
338 |
0.044
|
Human |
|
|
signal transduction by phosphorylation
|
GO:0023014 |
297 |
0.043
|
|
|
|
cytokine secretion
|
GO:0050663 |
64 |
0.043
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
177 |
0.042
|
|
|
|
actin filament organization
|
GO:0007015 |
128 |
0.042
|
|
|
|
cell cycle phase transition
|
GO:0044770 |
173 |
0.042
|
|
|
|
regulation of endothelial cell migration
|
GO:0010594 |
67 |
0.042
|
|
|
|
regulation of protein localization
|
GO:0032880 |
296 |
0.041
|
|
|
|
cellular component disassembly
|
GO:0022411 |
92 |
0.041
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
59 |
0.041
|
|
|
|
negative regulation of cytokine secretion
|
GO:0050710 |
20 |
0.041
|
|
|
|
endothelial cell migration
|
GO:0043542 |
86 |
0.041
|
|
|
|
regulation of dephosphorylation
|
GO:0035303 |
96 |
0.040
|
|
|
|
protein tetramerization
|
GO:0051262 |
47 |
0.040
|
Human |
|
|
regulation of establishment of protein localization
|
GO:0070201 |
242 |
0.039
|
|
|
|
carboxylic acid biosynthetic process
|
GO:0046394 |
97 |
0.039
|
|
|
|
positive regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043280 |
69 |
0.039
|
|
|
|
regulation of interleukin 8 production
|
GO:0032677 |
49 |
0.039
|
|
|
|
sphingolipid biosynthetic process
|
GO:0030148 |
18 |
0.039
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
148 |
0.038
|
|
|
|
negative regulation of peptidase activity
|
GO:0010466 |
91 |
0.038
|
Human |
|
|
regulation of anatomical structure morphogenesis
|
GO:0022603 |
286 |
0.038
|
|
|
|
cell morphogenesis
|
GO:0000902 |
296 |
0.038
|
|
|
|
g1 s transition of mitotic cell cycle
|
GO:0000082 |
78 |
0.038
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
183 |
0.038
|
|
|
|
regulation of actin cytoskeleton organization
|
GO:0032956 |
116 |
0.038
|
|
|
|
actin polymerization or depolymerization
|
GO:0008154 |
56 |
0.038
|
|
|
|
leukocyte activation
|
GO:0045321 |
164 |
0.038
|
|
|
|
tissue migration
|
GO:0090130 |
119 |
0.037
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
177 |
0.036
|
|
|
|
organophosphate ester transport
|
GO:0015748 |
32 |
0.036
|
|
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
118 |
0.036
|
|
|
|
negative regulation of secretion
|
GO:0051048 |
58 |
0.036
|
|
|
|
response to calcium ion
|
GO:0051592 |
46 |
0.035
|
Human |
|
|
diterpenoid metabolic process
|
GO:0016101 |
20 |
0.035
|
|
|
|
vesicle fusion
|
GO:0006906 |
17 |
0.035
|
Human |
|
|
hemopoiesis
|
GO:0030097 |
180 |
0.034
|
Human |
|
|
engulfment of apoptotic cell
|
GO:0043652 |
2 |
0.034
|
Worm |
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
412 |
0.034
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
437 |
0.034
|
|
|
|
positive regulation of developmental process
|
GO:0051094 |
314 |
0.034
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
119 |
0.034
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
284 |
0.033
|
|
|
|
sterol transport
|
GO:0015918 |
39 |
0.033
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
379 |
0.033
|
|
|
|
protein homooligomerization
|
GO:0051260 |
100 |
0.033
|
Human |
|
|
regulation of vasculature development
|
GO:1901342 |
97 |
0.033
|
|
|
|
negative regulation of protein transport
|
GO:0051224 |
75 |
0.032
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
170 |
0.032
|
Human |
|
|
cellular ketone metabolic process
|
GO:0042180 |
80 |
0.032
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
141 |
0.032
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
394 |
0.032
|
|
|
|
cellular component morphogenesis
|
GO:0032989 |
314 |
0.032
|
|
|
|
negative regulation of catalytic activity
|
GO:0043086 |
335 |
0.031
|
Human |
|
|
amine metabolic process
|
GO:0009308 |
44 |
0.031
|
|
|
|
cardiovascular system development
|
GO:0072358 |
262 |
0.031
|
Human |
|
|
regulated secretory pathway
|
GO:0045055 |
20 |
0.031
|
|
|
|
cell activation involved in immune response
|
GO:0002263 |
30 |
0.031
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
175 |
0.031
|
|
|
|
cytokinesis
|
GO:0000910 |
96 |
0.030
|
Human |
|
|
tissue remodeling
|
GO:0048771 |
16 |
0.030
|
Human |
|
|
single organism cellular localization
|
GO:1902580 |
332 |
0.030
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
156 |
0.030
|
|
|
|
cholesterol efflux
|
GO:0033344 |
28 |
0.030
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
393 |
0.029
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
267 |
0.029
|
|
|
|
regeneration
|
GO:0031099 |
4 |
0.029
|
|
|
|
response to abiotic stimulus
|
GO:0009628 |
336 |
0.029
|
|
|
|
positive regulation of cellular component movement
|
GO:0051272 |
181 |
0.028
|
|
|
|
gtp catabolic process
|
GO:0006184 |
237 |
0.028
|
|
|
|
protein localization to membrane
|
GO:0072657 |
160 |
0.028
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
355 |
0.028
|
|
|
|
blood vessel development
|
GO:0001568 |
172 |
0.028
|
Human |
|
|
ribonucleotide catabolic process
|
GO:0009261 |
405 |
0.028
|
|
|
|
negative regulation of g1 s transition of mitotic cell cycle
|
GO:2000134 |
29 |
0.028
|
|
|
|
regulation of cell morphogenesis
|
GO:0022604 |
153 |
0.027
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
116 |
0.027
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
125 |
0.027
|
Human |
|
|
mitotic cell cycle process
|
GO:1903047 |
286 |
0.027
|
|
|
|
positive regulation of endothelial cell migration
|
GO:0010595 |
39 |
0.027
|
|
|
|
oogenesis
|
GO:0048477 |
2 |
0.027
|
Worm |
|
|
neutrophil homeostasis
|
GO:0001780 |
3 |
0.027
|
Human |
|
|
system process
|
GO:0003008 |
349 |
0.027
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
193 |
0.027
|
|
|
|
positive regulation of defense response
|
GO:0031349 |
87 |
0.026
|
|
|
|
negative regulation of secretion by cell
|
GO:1903531 |
52 |
0.026
|
|
|
|
cell cycle checkpoint
|
GO:0000075 |
117 |
0.026
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
392 |
0.026
|
|
|
|
negative regulation of serine type endopeptidase activity
|
GO:1900004 |
2 |
0.026
|
Human |
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
182 |
0.026
|
Human |
|
|
negative regulation of multicellular organismal process
|
GO:0051241 |
317 |
0.026
|
|
|
|
locomotory behavior
|
GO:0007626 |
1 |
0.026
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
211 |
0.025
|
|
|
|
regulation of cysteine type endopeptidase activity
|
GO:2000116 |
127 |
0.025
|
|
|
|
negative regulation of protein secretion
|
GO:0050709 |
29 |
0.025
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
135 |
0.025
|
|
|
|
peptide metabolic process
|
GO:0006518 |
51 |
0.025
|
|
|
|
regulation of immune effector process
|
GO:0002697 |
91 |
0.025
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
289 |
0.024
|
|
|
|
neutrophil activation involved in immune response
|
GO:0002283 |
3 |
0.024
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
353 |
0.024
|
Human |
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
140 |
0.024
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
269 |
0.024
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
179 |
0.024
|
|
|
|
leukocyte activation involved in immune response
|
GO:0002366 |
30 |
0.024
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
82 |
0.024
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
101 |
0.024
|
|
|
|
regulation of rho protein signal transduction
|
GO:0035023 |
79 |
0.024
|
|
|
|
response to steroid hormone
|
GO:0048545 |
80 |
0.023
|
Human |
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
186 |
0.023
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
326 |
0.023
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
70 |
0.023
|
|
|
|
cell cycle g1 s phase transition
|
GO:0044843 |
80 |
0.023
|
|
|
|
cell adhesion
|
GO:0007155 |
325 |
0.023
|
|
|
|
regulation of exocytosis
|
GO:0017157 |
46 |
0.023
|
|
|
|
regulation of serine type peptidase activity
|
GO:1902571 |
2 |
0.023
|
Human |
|
|
negative regulation of protein modification process
|
GO:0031400 |
200 |
0.023
|
|
|
|
cellular response to oxygen containing compound
|
GO:1901701 |
276 |
0.023
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
379 |
0.023
|
|
|
|
cellular response to endogenous stimulus
|
GO:0071495 |
336 |
0.023
|
Human |
|
|
mitotic cell cycle phase transition
|
GO:0044772 |
162 |
0.023
|
|
|
|
lipid catabolic process
|
GO:0016042 |
84 |
0.022
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
266 |
0.022
|
|
|
|
response to nitrogen compound
|
GO:1901698 |
184 |
0.022
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
101 |
0.022
|
|
|
|
cd4 positive alpha beta t cell cytokine production
|
GO:0035743 |
4 |
0.022
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
111 |
0.022
|
|
|
|
response to virus
|
GO:0009615 |
126 |
0.022
|
|
|
|
epithelial cell migration
|
GO:0010631 |
119 |
0.022
|
|
|
|
osteoclast development
|
GO:0036035 |
2 |
0.022
|
Human |
|
|
membrane raft assembly
|
GO:0001765 |
7 |
0.021
|
Human |
|
|
actin cytoskeleton organization
|
GO:0030036 |
207 |
0.021
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
92 |
0.021
|
|
|
|
activation of cysteine type endopeptidase activity
|
GO:0097202 |
57 |
0.021
|
|
|
|
regulation of protein depolymerization
|
GO:1901879 |
22 |
0.021
|
|
|
|
post golgi vesicle mediated transport
|
GO:0006892 |
36 |
0.021
|
|
|
|
regulation of cell cycle g1 s phase transition
|
GO:1902806 |
42 |
0.021
|
|
|
|
positive regulation of sequence specific dna binding transcription factor activity
|
GO:0051091 |
131 |
0.021
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
281 |
0.021
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
411 |
0.020
|
|
|
|
positive regulation of neutrophil apoptotic process
|
GO:0033031 |
1 |
0.020
|
|
|
|
regulation of actin polymerization or depolymerization
|
GO:0008064 |
56 |
0.020
|
|
|
|
positive regulation of epithelial cell migration
|
GO:0010634 |
55 |
0.020
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
188 |
0.020
|
|
|
|
neutral lipid metabolic process
|
GO:0006638 |
27 |
0.020
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
408 |
0.020
|
|
|
|
positive regulation of exocytosis
|
GO:0045921 |
35 |
0.020
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
207 |
0.020
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
127 |
0.020
|
Human |
|
|
lymphocyte mediated immunity
|
GO:0002449 |
48 |
0.020
|
|
|
|
response to tumor necrosis factor
|
GO:0034612 |
76 |
0.020
|
|
|
|
negative regulation of endopeptidase activity
|
GO:0010951 |
84 |
0.019
|
Human |
|
|
golgi vesicle transport
|
GO:0048193 |
80 |
0.019
|
|
|
|
endocytosis
|
GO:0006897 |
159 |
0.019
|
Human Worm |
|
|
regulation of i kappab kinase nf kappab signaling
|
GO:0043122 |
162 |
0.019
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
413 |
0.019
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
430 |
0.019
|
|
|
|
autophagy
|
GO:0006914 |
88 |
0.019
|
Human |
|
|
negative regulation of transferase activity
|
GO:0051348 |
124 |
0.019
|
|
|
|
endosomal transport
|
GO:0016197 |
129 |
0.019
|
Human |
|
|
cellular protein complex disassembly
|
GO:0043624 |
36 |
0.019
|
|
|
|
lymphocyte activation
|
GO:0046649 |
133 |
0.019
|
|
|
|
regulation of actin filament length
|
GO:0030832 |
56 |
0.019
|
|
|
|
negative regulation of sequence specific dna binding transcription factor activity
|
GO:0043433 |
89 |
0.019
|
|
|
|
heterotypic cell cell adhesion
|
GO:0034113 |
28 |
0.019
|
|
|
|
post embryonic development
|
GO:0009791 |
2 |
0.019
|
|
|
|
negative regulation of programmed cell death
|
GO:0043069 |
321 |
0.019
|
|
|
|
negative regulation of cell cycle phase transition
|
GO:1901988 |
89 |
0.018
|
|
|
|
regulation of sterol transport
|
GO:0032371 |
21 |
0.018
|
|
|
|
positive regulation of phosphorylation
|
GO:0042327 |
394 |
0.018
|
|
|
|
regulation of protein complex assembly
|
GO:0043254 |
147 |
0.018
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
195 |
0.018
|
|
|
|
hematopoietic or lymphoid organ development
|
GO:0048534 |
186 |
0.018
|
Human |
|
|
cytokinetic process
|
GO:0032506 |
12 |
0.018
|
Human |
|
|
regulation of leukocyte activation
|
GO:0002694 |
115 |
0.018
|
|
|
|
cellular response to steroid hormone stimulus
|
GO:0071383 |
37 |
0.018
|
Human |
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
267 |
0.018
|
|
|
|
inflammatory response
|
GO:0006954 |
79 |
0.018
|
|
|
|
organic acid catabolic process
|
GO:0016054 |
71 |
0.017
|
|
|
|
positive regulation of gtp catabolic process
|
GO:0033126 |
166 |
0.017
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
227 |
0.017
|
|
|
|
cell development
|
GO:0048468 |
328 |
0.017
|
Human Worm |
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
209 |
0.017
|
|
|
|
intracellular protein transport
|
GO:0006886 |
270 |
0.017
|
|
|
|
neutrophil apoptotic process
|
GO:0001781 |
2 |
0.017
|
|
|
|
cellular amide metabolic process
|
GO:0043603 |
69 |
0.017
|
|
|
|
cellular homeostasis
|
GO:0019725 |
196 |
0.017
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
405 |
0.017
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
140 |
0.017
|
|
|
|
mitotic dna integrity checkpoint
|
GO:0044774 |
30 |
0.017
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
122 |
0.017
|
|
|
|
positive regulation of myeloid cell apoptotic process
|
GO:0033034 |
2 |
0.017
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
136 |
0.017
|
|
|
|
regulation of lipid transport
|
GO:0032368 |
44 |
0.017
|
|
|
|
positive regulation of ras gtpase activity
|
GO:0032320 |
117 |
0.017
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
136 |
0.017
|
|
|
|
blastoderm segmentation
|
GO:0007350 |
2 |
0.017
|
|
|
|
positive regulation of gtpase activity
|
GO:0043547 |
166 |
0.017
|
|
|
|
positive regulation of nucleotide catabolic process
|
GO:0030813 |
185 |
0.016
|
|
|
|
nucleoside phosphate biosynthetic process
|
GO:1901293 |
109 |
0.016
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
228 |
0.016
|
|
|
|
hormone metabolic process
|
GO:0042445 |
61 |
0.016
|
|
|
|
sterol homeostasis
|
GO:0055092 |
28 |
0.016
|
|
|
|
positive regulation of cytoskeleton organization
|
GO:0051495 |
83 |
0.016
|
|
|
|
negative regulation of protein kinase activity
|
GO:0006469 |
98 |
0.016
|
|
|
|
response to drug
|
GO:0042493 |
81 |
0.016
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
174 |
0.016
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
127 |
0.016
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
314 |
0.016
|
|
|
|
terpenoid metabolic process
|
GO:0006721 |
27 |
0.016
|
|
|
|
negative regulation of interleukin 8 production
|
GO:0032717 |
12 |
0.015
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
103 |
0.015
|
|
|
|
acylglycerol metabolic process
|
GO:0006639 |
27 |
0.015
|
|
|
|
intrinsic apoptotic signaling pathway in response to dna damage
|
GO:0008630 |
50 |
0.015
|
|
|
|
brain development
|
GO:0007420 |
97 |
0.015
|
|
|
|
positive regulation of locomotion
|
GO:0040017 |
186 |
0.015
|
|
|
|
i kappab kinase nf kappab signaling
|
GO:0007249 |
166 |
0.015
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
205 |
0.015
|
|
|
|
mitotic cell cycle checkpoint
|
GO:0007093 |
68 |
0.015
|
|
|
|
plasma membrane organization
|
GO:0007009 |
115 |
0.015
|
|
|
|
negative regulation of nf kappab transcription factor activity
|
GO:0032088 |
51 |
0.015
|
|
|
|
negative regulation of transport
|
GO:0051051 |
176 |
0.015
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
157 |
0.015
|
|
|
|
cholesterol homeostasis
|
GO:0042632 |
28 |
0.015
|
|
|
|
positive regulation of protein complex assembly
|
GO:0031334 |
86 |
0.015
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
73 |
0.015
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.015
|
|
|
|
regulation of g1 s transition of mitotic cell cycle
|
GO:2000045 |
40 |
0.015
|
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
172 |
0.015
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
404 |
0.015
|
|
|
|
cellular macromolecular complex assembly
|
GO:0034622 |
324 |
0.014
|
|
|
|
cellular response to starvation
|
GO:0009267 |
58 |
0.014
|
|
|
|
cell fate determination
|
GO:0001709 |
3 |
0.014
|
|
|
|
alcohol biosynthetic process
|
GO:0046165 |
52 |
0.014
|
|
|
|
regulation of innate immune response
|
GO:0045088 |
97 |
0.014
|
|
|
|
glycerolipid biosynthetic process
|
GO:0045017 |
51 |
0.014
|
|
|
|
actin nucleation
|
GO:0045010 |
21 |
0.014
|
|
|
|
head development
|
GO:0060322 |
108 |
0.014
|
|
|
|
epidermis development
|
GO:0008544 |
59 |
0.014
|
Human |
|
|
mating
|
GO:0007618 |
1 |
0.014
|
|
|
|
regulation of protein stability
|
GO:0031647 |
87 |
0.014
|
|
|
|
primary alcohol metabolic process
|
GO:0034308 |
17 |
0.014
|
|
|
|
limbic system development
|
GO:0021761 |
3 |
0.014
|
|
|
|
symbiosis encompassing mutualism through parasitism
|
GO:0044403 |
156 |
0.014
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
406 |
0.014
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
75 |
0.014
|
|
|
|
activation of immune response
|
GO:0002253 |
114 |
0.014
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
108 |
0.014
|
|
|
|
zymogen activation
|
GO:0031638 |
70 |
0.014
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
34 |
0.014
|
Human |
|
|
glycoprotein biosynthetic process
|
GO:0009101 |
91 |
0.014
|
|
|
|
female gamete generation
|
GO:0007292 |
2 |
0.014
|
Worm |
|
|
peroxisome organization
|
GO:0007031 |
28 |
0.014
|
|
|
|
regulation of defense response
|
GO:0031347 |
154 |
0.013
|
|
|
|
regulation of ion transmembrane transport
|
GO:0034765 |
132 |
0.013
|
|
|
|
blood coagulation
|
GO:0007596 |
76 |
0.013
|
|
|
|
retrograde transport endosome to golgi
|
GO:0042147 |
45 |
0.013
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
391 |
0.013
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
235 |
0.013
|
|
|
|
positive regulation of homeostatic process
|
GO:0032846 |
47 |
0.013
|
|
|
|
axon cargo transport
|
GO:0008088 |
2 |
0.013
|
|
|
|
mitochondrion organization
|
GO:0007005 |
156 |
0.013
|
|
|
|
hormone biosynthetic process
|
GO:0042446 |
22 |
0.013
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
152 |
0.013
|
|
|
|
negative regulation of protein serine threonine kinase activity
|
GO:0071901 |
57 |
0.013
|
|
|
|
segmentation
|
GO:0035282 |
4 |
0.013
|
|
|
|
protein depolymerization
|
GO:0051261 |
30 |
0.013
|
|
|
|
membrane assembly
|
GO:0071709 |
10 |
0.013
|
Human |
|
|
wound healing
|
GO:0042060 |
115 |
0.013
|
|
|
|
mitotic g1 dna damage checkpoint
|
GO:0031571 |
17 |
0.013
|
|
|
|
regulation of small gtpase mediated signal transduction
|
GO:0051056 |
156 |
0.013
|
|
|
|
negative regulation of mitotic cell cycle phase transition
|
GO:1901991 |
85 |
0.013
|
|
|
|
ribose phosphate biosynthetic process
|
GO:0046390 |
82 |
0.013
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
412 |
0.013
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
139 |
0.012
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
213 |
0.012
|
|
|
|
establishment of protein localization to plasma membrane
|
GO:0090002 |
68 |
0.012
|
|
|
|
negative regulation of mapk cascade
|
GO:0043409 |
56 |
0.012
|
|
|
|
establishment of protein localization to membrane
|
GO:0090150 |
121 |
0.012
|
|
|
|
neurogenesis
|
GO:0022008 |
169 |
0.012
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
398 |
0.012
|
|
|
|
response to wounding
|
GO:0009611 |
168 |
0.012
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
11 |
0.012
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
167 |
0.012
|
|
|
|
positive regulation of cell proliferation
|
GO:0008284 |
301 |
0.012
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
205 |
0.012
|
|
|
|
organic hydroxy compound biosynthetic process
|
GO:1901617 |
71 |
0.012
|
|
|
|
positive regulation of immune effector process
|
GO:0002699 |
40 |
0.012
|
|
|
|
positive regulation of rho gtpase activity
|
GO:0032321 |
56 |
0.012
|
|
|
|
myeloid leukocyte activation
|
GO:0002274 |
34 |
0.012
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
169 |
0.012
|
|
|
|
cell projection morphogenesis
|
GO:0048858 |
129 |
0.012
|
|
|
|
negative regulation of cell cycle process
|
GO:0010948 |
121 |
0.012
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
422 |
0.012
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
391 |
0.012
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
244 |
0.012
|
|
|
|
signal transduction by p53 class mediator
|
GO:0072331 |
72 |
0.012
|
|
|
|
protein polymerization
|
GO:0051258 |
71 |
0.012
|
|
|
|
phospholipid metabolic process
|
GO:0006644 |
99 |
0.012
|
|
|
|
response to starvation
|
GO:0042594 |
59 |
0.012
|
|
|
|
regulation of response to external stimulus
|
GO:0032101 |
222 |
0.012
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
98 |
0.012
|
Human |
|
|
blood vessel endothelial cell migration
|
GO:0043534 |
42 |
0.011
|
|
|
|
response to nutrient levels
|
GO:0031667 |
81 |
0.011
|
|
|
|
cardiac muscle cell contraction
|
GO:0086003 |
4 |
0.011
|
|
|
|
positive regulation of purine nucleotide catabolic process
|
GO:0033123 |
185 |
0.011
|
|
|
|
cell projection organization
|
GO:0030030 |
252 |
0.011
|
|
|
|
neutrophil degranulation
|
GO:0043312 |
3 |
0.011
|
|
|
|
central nervous system development
|
GO:0007417 |
123 |
0.011
|
|
|
|
hemostasis
|
GO:0007599 |
76 |
0.011
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
176 |
0.011
|
|
|
|
regulation of protein processing
|
GO:0070613 |
150 |
0.011
|
Human |
|
|
homeostasis of number of cells
|
GO:0048872 |
40 |
0.011
|
Human |
|
|
mitotic dna damage checkpoint
|
GO:0044773 |
28 |
0.011
|
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
180 |
0.011
|
|
|
|
apoptotic cell clearance
|
GO:0043277 |
12 |
0.011
|
Worm |
|
|
regulation of lipase activity
|
GO:0060191 |
37 |
0.011
|
Human |
|
|
ribonucleotide biosynthetic process
|
GO:0009260 |
81 |
0.011
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
82 |
0.011
|
|
|
|
oxidation reduction process
|
GO:0055114 |
396 |
0.011
|
|
|
|
positive regulation of i kappab kinase nf kappab signaling
|
GO:0043123 |
132 |
0.011
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
46 |
0.011
|
|
|
|
meiosis i
|
GO:0007127 |
4 |
0.011
|
|
|
|
regulation of protein dephosphorylation
|
GO:0035304 |
18 |
0.011
|
|
|
|
actin filament polymerization
|
GO:0030041 |
45 |
0.011
|
|
|
|
spermatid differentiation
|
GO:0048515 |
4 |
0.010
|
|
|
|
isoprenoid metabolic process
|
GO:0006720 |
39 |
0.010
|
|
|
|
apoptotic mitochondrial changes
|
GO:0008637 |
57 |
0.010
|
|
|
|
regulation of cell activation
|
GO:0050865 |
125 |
0.010
|
|
|
|
amide biosynthetic process
|
GO:0043604 |
15 |
0.010
|
|
|
|
macromolecular complex disassembly
|
GO:0032984 |
60 |
0.010
|
|
|
|
natural killer cell activation involved in immune response
|
GO:0002323 |
2 |
0.010
|
|
|
|
positive regulation of protein dephosphorylation
|
GO:0035307 |
16 |
0.010
|
|
|
|
epidermal cell differentiation
|
GO:0009913 |
45 |
0.010
|
Human |
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
155 |
0.010
|
|